$2.28 Billion is the total value of LINDEN ADVISORS LP's 92 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | DEPOMED INC 2.5 1SEP21sdbcv | $70,904,000 | – | 58,650,000 | +100.0% | 3.11% | – | |
| New | CTRIP.COM INTL LT 1.99 01JUL25sdbcv | $70,646,000 | – | 65,170,000 | +100.0% | 3.10% | – | |
| New | AMERICAN RESIDENTIAL 3.25% 15NOV18sdbcv | $55,266,000 | – | 46,500,000 | +100.0% | 2.42% | – | |
| New | VIPSHOP HLDG LTD 1.5% 15MAR19sdbcv | $39,402,000 | – | 39,900,000 | +100.0% | 1.73% | – | |
| New | FIREEYE INC 1% 1JUN35sdbcv | $28,869,000 | – | 31,798,000 | +100.0% | 1.26% | – | |
| New | HORIZON PHARMA 2.5 15MAR22sdb | $28,448,000 | – | 31,091,000 | +100.0% | 1.25% | – | |
| New | CTRIP.COM INTL LTD 1% 01JUL20sdbcv | $24,811,000 | – | 23,485,000 | +100.0% | 1.09% | – | |
| New | IRONWOOD PHARMAC 2.25% 15JUN22sdbcv | $24,084,000 | – | 23,267,000 | +100.0% | 1.06% | – | |
| EFA | New | ISHARES MSCI EAFE INDEX FUNDcall | $16,746,000 | – | 300,000 | +100.0% | 0.73% | – |
| SPY | New | S&P 500 DEPOSITORY RECEIPT | $16,762,000 | – | 80,000 | +100.0% | 0.73% | – |
| GLBL | New | TERRAFORM GLOBAL INC - CL A | $14,592,000 | – | 4,475,701 | +100.0% | 0.64% | – |
| New | TIMKENSTEEL 6% 1JUN21sdb | $13,731,000 | – | 13,000,000 | +100.0% | 0.60% | – | |
| New | EMERGENT BIOSOL 2.875 15JAN21sdbcv | $12,502,000 | – | 11,000,000 | +100.0% | 0.55% | – | |
| New | ENDOLOGIX INC 3.25 1NOV20sdbcv | $12,165,000 | – | 9,319,000 | +100.0% | 0.53% | – | |
| New | YY INC 2.25 1APR19sdbcv | $12,137,000 | – | 12,351,000 | +100.0% | 0.53% | – | |
| New | CONSOLIDATED-TOM 4.5 15MAR20sdb | $11,339,000 | – | 12,000,000 | +100.0% | 0.50% | – | |
| EEM | New | ISHARES MSCI EMERGING MKT INcall | $10,308,000 | – | 300,000 | +100.0% | 0.45% | – |
| New | REPLIGEN CORP 2.125% 01JUN21sdbcv | $10,282,000 | – | 9,500,000 | +100.0% | 0.45% | – | |
| New | JAZZ INVESTMENTS 1.875 15AUG21sdbcv | $9,966,000 | – | 9,258,000 | +100.0% | 0.44% | – | |
| New | PALO ALTO NET 0 1JUL19sdbcv | $9,579,000 | – | 7,500,000 | +100.0% | 0.42% | – | |
| New | INTERACTIVE I 1.25% 01JUN20sdbcv | $9,506,000 | – | 10,000,000 | +100.0% | 0.42% | – | |
| New | NEVRO CORP 1.75% 01JUN21sdbcv | $8,423,000 | – | 8,000,000 | +100.0% | 0.37% | – | |
| EAGLU | New | DOUBLE EAGLE ACQUISITION COR | $7,351,000 | – | 750,000 | +100.0% | 0.32% | – |
| DYNC | New | DYNEGY INC 7% 1JUL19cvpfd | $6,446,000 | – | 60,000 | +100.0% | 0.28% | – |
| New | MEDICINES COMPANY 2.5 15JAN22sdbcv | $5,930,000 | – | 5,000,000 | +100.0% | 0.26% | – | |
| AAPL | New | APPLE INC | $5,238,000 | – | 54,794 | +100.0% | 0.23% | – |
| PACEU | New | PACE HOLDINGS CORP | $4,547,000 | – | 454,739 | +100.0% | 0.20% | – |
| New | WHITING PETROLEUM 1.25% 1APR20sdbcv | $2,793,000 | – | 3,500,000 | +100.0% | 0.12% | – | |
| MSFT | New | MICROSOFT CORP | $2,796,000 | – | 54,629 | +100.0% | 0.12% | – |
| CY | New | CYPRESS SEMICONDUCTOR CORP | $2,415,000 | – | 228,925 | +100.0% | 0.11% | – |
| New | ILLUMINA INC 0% 15JUN19sdbcv | $1,468,000 | – | 1,500,000 | +100.0% | 0.06% | – | |
| ICPT | New | INTERCEPT PHARMACEUTICALS IN | $1,329,000 | – | 9,316 | +100.0% | 0.06% | – |
| ON | New | ON SEMICONDUCTOR CORP | $322,000 | – | 36,500 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SUNPOWER CORP 4 15JAN23 | 25 | Q4 2022 | 1.3% |
| COLONY FINANCIA 3.875% 15JAN21 | 24 | Q2 2020 | 5.9% |
| VECTOR GROUP LTD 1.75% 15APR20 | 22 | Q3 2019 | 7.2% |
| COLONY FINANCIAL 5% 15APR23 | 22 | Q2 2020 | 1.2% |
| HELIX ENER SOLUT 4.125 15SEP23 | 22 | Q2 2023 | 1.4% |
| APOLLO CMMRL REAL EST FI 5.375 10/15/2023 | 20 | Q3 2023 | 2.0% |
| HERBALIFE LTD 2.625 15MAR24 | 19 | Q3 2023 | 1.5% |
| OPKO HEALTH INC 4.5 15FEB25 | 19 | Q3 2023 | 0.7% |
| APOLLO CRLREALEST 4.75 23AUG22 | 18 | Q4 2021 | 4.7% |
| IRONWOOD PHARMACEUTICALS 2.25 06/15/2022 | 18 | Q3 2020 | 3.6% |
View LINDEN ADVISORS LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| TETRALOGIC PHARMACEUTICALS CORPSold out | November 14, 2016 | 0 | 0.0% |
View LINDEN ADVISORS LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View LINDEN ADVISORS LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.